(Q40513340)

21 September 2017

Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination (English)

1 reference

21 September 2017

2

1 reference

21 September 2017

5

1 reference

21 September 2017

Robert A Vierkant

3

0 references

Gregory A. Poland

series ordinal

6

object named as

Gregory A Poland

1 reference

21 September 2017

1

Inna G Ovsyannikova

1 reference

21 September 2017

V Shane Pankratz

4

1 reference

PubMed ID

15121303

21 September 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

21 September 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 September 2017

22

1 reference

21 September 2017

15-16

1 reference

21 September 2017

1914-1920

1 reference

Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Measles elimination: progress and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Measles reimmunization in children seronegative after initial immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

The genetic basis for variation in antibody response to vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Twin studies of immunogenicity--determining the genetic contribution to vaccine failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Structural basis of T cell recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

The role of mass spectrometry in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Immunogenetic mechanisms of antibody response to measles vaccine: the role of the HLA genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

The association of class I HLA alleles and antibody levels after a single dose of measles vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Identification of an association between HLA class II alleles and low antibody levels after measles immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Associations between Human Leukocyte Antigen Homozygosity and Antibody Levels to Measles Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Relationship of HLA-DQAI alleles and humoral antibody following measles vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

A recovered avian myelocytomatosis virus that induces lymphomas in chickens: pathogenic properties and their molecular basis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

HLA-DPA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) and distribution of DPA1 alleles in Caucasian, African and Oriental populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Genetic prediction of nonresponse to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Frequency of HLA-DPB1 disparities detected by reference strand-mediated conformation analysis in HLA-A, -B, and -DRB1 matched siblings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Enzyme-linked immunosorbent assay for detection of measles antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.11.016

1 reference

21 September 2017

1 reference

PubMed ID

15121303